DHTKD1 and neoplasm: Using this system, we generated a recombinant BtAdV mutant in which the canine telomerase reverse transcriptase promoter22, a tumor-specific promoter, was inserted into its E1A regulatory region, so that this recombinant virus could selectively express E1A protein and efficiently replicate in tumor cells.